Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Androgen receptor (Homo sapiens (Human)) | BDBM238895 (US10053433, Casodex (CDX) | US10053433, FC 4.037 (...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM238895 (US10053433, Casodex (CDX) | US10053433, FC 4.037 (...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM238895 (US10053433, Casodex (CDX) | US10053433, FC 4.037 (...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 360 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM239191 (US10053433, FC 3.077) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 490 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM242618 (US10053433, FC 4.025) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 580 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM242588 (US10053433, FC 4.039) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM238895 (US10053433, Casodex (CDX) | US10053433, FC 4.037 (...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM242618 (US10053433, FC 4.025) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.29E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM239363 (US10053433, FC 4.126) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.55E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50425732 (ENZALUTAMIDE | US10053433, FC 4.129 | US10806720, ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase DrugBank MCE PC cid PC sid UniChem Similars | DrugBank US Patent | n/a | n/a | 1.94E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM239316 (US10053433, FC 4.116) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.53E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50094975 (956104-40-8 | ARN-509 | JNJ-56021927 | US10053433,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.11E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50094975 (956104-40-8 | ARN-509 | JNJ-56021927 | US10053433,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.28E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM242578 (US10053433, FC 4.127) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.26E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50425732 (ENZALUTAMIDE | US10053433, FC 4.129 | US10806720, ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase DrugBank MCE PC cid PC sid UniChem Similars | DrugBank US Patent | n/a | n/a | 8.61E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM242578 (US10053433, FC 4.127) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.74E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM239363 (US10053433, FC 4.126) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.24E+4 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM50094975 (956104-40-8 | ARN-509 | JNJ-56021927 | US10053433,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.95E+4 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM239507 (US10053433, FC 4.125) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.24E+4 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description Briefly, the AR LBD is expressed as a fusion with the Gal4 transcription factor, which binds to the Gal4 reporter DNA. Upon activation with agonist h... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Androgen receptor (Homo sapiens (Human)) | BDBM239316 (US10053433, FC 4.116) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.17E+4 | n/a | n/a | n/a | n/a | 7.5 | n/a |
The Regents of the University of California US Patent | Assay Description An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antago... | US Patent US10053433 (2018) BindingDB Entry DOI: 10.7270/Q2R78H77 | |||||||||||
More data for this Ligand-Target Pair |